Futura Medical plc (FRA:GYX)

Market Cap	3.38M -89.3%
Revenue (ttm)	1.94M -87.8%
Net Income	-10.40M
EPS	-0.03
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0020
Previous Close	0.0015
Day's Range	0.0020 - 0.0020
52-Week Range	0.0015 - 0.1750
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 11, 2026

About Futura Medical

Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company’s lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 13
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: GYX

Financial Performance

Financial numbers in GBP

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error